Q & A with 2014 CTSI Faculty Pilot Awardee
|
|
In the most recent CTSI Stories Blog, Carla Beckham, M.D., Ph.D., assistant professor of Urology at URMC, who worked with Edward Messing, M.D., professor of Urology at URMC on a 2014 CTSI Faculty Pilot project, shares information about treatment for bladder cancer, the fifth most common cancer and the most expensive to treat over a patient’s lifetime. She discusses how the Pilot Award gave her career a huge launch into the field of exosome research, an exciting new direction for this particular cancer. To read the full CTSI Stories Blog and learn more about the Pilot Studies Program, click here.
|
|
Wilmot Cancer Institute NCI Designation
|
|
One year ago, the Wilmot Cancer Institute began a concerted effort to prepare an application for National Cancer Institute designation by 2021. The NCI-Designated Cancer Centers are recognized for their scientific leadership, resources, and the depth and breadth of their research in basic, clinical, and/or population science as well as substantial transdisciplinary research that bridges these scientific areas.
Wilmot Cancer Institute Director, Jonathan W. Friedberg, M.D., M.M.Sc. shares information about important progress made over the past year in a video on the Wilmot intranet site. To view the video, click here.
More information about the NCI-Designated Cancer Centers can be found here.
|
|
Technology Development Fund
Offers Awards Up To $100,000
|
|
Applications are now being accepted for spring 2017 University Technology Development Fund awards of up to $100,000.
Any faculty member, post-doctoral fellow, graduate student, or other employee of the University of Rochester is eligible to apply for funding. Applications for technologies from all fields of science, medicine, dentistry, nursing, business, education, music, and engineering will be accepted.
Submissions should be sent to omar.bakht@rochester.edu. Eligible projects should propose the development of a technology to a commercial endpoint. An invention disclosure must be filed with UR Ventures. Non-inventor developers can propose to develop technology that they did not invent.
The deadline for pre-proposals is Tuesday, May 23, 2017.
Click here for additional information.
|
|
Last Call for Community Health
Mini-Grant Applications
|
|
The Center for Community Health is accepting Community Health Mini-Grant Applications for a grant to be awarded in May 2017. This competitive grant program began in February 2009 in response to faculty and staff surveys that considered ways to address barriers to pursuing community health partnerships. It has provided URMC and community partnerships with additional funding to address issues such as transportation, childcare, meeting space rental, refreshments for meetings, etc. Grant funding up to $1,000 is made on a quarterly basis. Applications are welcome from either URMC or community partners.
The application deadline is Wednesday, May 10, 2017, 12:00 pm.
Click here for the application and instructions, or call 585-224-3062 at the Center for Community Health.
|
|
The Chemokine CCL3in the
Leukemia Microenvironment
|
|
Presented by: Benjamin Frisch, PhD, Research Assistant Professor, Division of Hematology/Oncology, Wilmot Cancer Institute, URMC, Faculty Candidate, Cancer Biology, Wilmot Cancer Institute
Discovery of mechanisms of support for hematopoietic stem cell (HSC) during both homeostatic and stressed hematopoiesis has evolved to the identification of novel therapeutic targets in malignant hematopoiesis, such as acute myeloid leukemia. His current research is focused on alterations of the bone marrow microenvironment induced by myeloid malignancies, which has led to the identification of the chemokine CCL3 as a potential target for the treatment of acute myeloid leukemia.
Date: Monday, May 8th
Time: 2:00 – 3:00 pm
Location: WCI Formicola Conference Room (2-0727)
|
|
Workshop on
Chromosome Conformation Capture (3C)
|
|
|
|
|